Dr. M.A Athar, MD
What this data tells you about Dr. Athar
Dr. M.A Athar is an internal medicine specialist in Mckinney, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Athar performed 83,792 Medicare services across 3,219 unique beneficiaries.
Between the years covered by Open Payments, Dr. Athar received a total of $5,325 from 40 pharmaceutical and/or device companies across 205 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Athar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 31,700 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 11,500 | $34 | $136 |
| Contrast dye for imaging (iodine-based) | 10,391 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) | 8,250 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia | 5,990 | $2 | $20 |
| Immune globulin infusion (Octagam) | 4,264 | $34 | $235 |
| Denosumab injection (Prolia/Xgeva) | 2,220 | $18 | $66 |
| Dexamethasone injection (steroid) | 1,136 | $0 | $1 |
| Blood draw (venipuncture) | 907 | $8 | $20 |
| Comprehensive metabolic blood panel | 837 | $10 | $64 |
| Complete blood count (CBC) with differential | 829 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 680 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 560 | $1 | $114 |
| Magnesium level test | 398 | $6 | $29 |
| Office visit, established patient (20-29 min) | 377 | $64 | $250 |
| Injection of additional new drug or substance into vein | 339 | $12 | $108 |
| Lactate dehydrogenase (enzyme) level | 282 | $6 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 271 | $47 | $313 |
| Injection, zoledronic acid, 1 mg | 269 | $6 | $431 |
| Administration of chemotherapy into vein, 1 hour or less | 234 | $94 | $707 |
| Office visit, established patient (30-39 min) | 182 | $92 | $368 |
| Ferritin level test (iron stores) | 154 | $13 | $60 |
| Iron level test | 154 | $6 | $27 |
| Iron binding capacity test | 154 | $8 | $35 |
| Drug injection, under skin or into muscle | 134 | $11 | $96 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 116 | $53 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 99 | $16 | $100 |
| Ct scan of chest with contrast | 98 | $45 | $821 |
| CT scan of abdomen and pelvis with contrast | 92 | $167 | $1,067 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 86 | $70 | $70 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 81 | $22 | $157 |
| Infusion, normal saline solution , 1000 cc | 80 | $2 | $19 |
| New patient office visit (45-59 min) | 74 | $122 | $565 |
| Microscopic examination for white blood cells with manual cell count | 66 | $4 | $22 |
| Complete blood count (CBC), automated | 66 | $6 | $34 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 54 | $89 | $657 |
| Administration of additional new drug or substance into vein, 1 hour or less | 48 | $49 | $344 |
| Injection, lorazepam, 2 mg | 47 | $1 | $3 |
| CT scan of chest, without contrast | 46 | $50 | $686 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 46 | $1,106 | $4,802 |
| Carcinoembryonic antigen (cea) protein level | 44 | $19 | $99 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 41 | $1 | $19 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $25 | $145 |
| Administration of chemotherapy into vein, each additional hour | 38 | $21 | $161 |
| Injection, diphenhydramine hcl, up to 50 mg | 37 | $1 | $7 |
| Urinalysis with microscopic exam | 33 | $3 | $28 |
| Infusion into a vein for hydration, 31-60 minutes | 32 | $23 | $256 |
| Hospital follow-up visit, moderate complexity | 32 | $61 | $247 |
| New patient office visit, complex (60-74 min) | 26 | $158 | $709 |
| Injection of drug or substance into vein | 24 | $28 | $247 |
| Ct scan of soft tissue of neck with contrast | 18 | $52 | $658 |
| PSA test (prostate cancer screening) | 18 | $18 | $94 |
| Red blood count automated, with additional calculations | 18 | $5 | $26 |
| Irrigation of implanted venous access drug delivery device | 18 | $18 | $114 |
| Drawing of blood for a medical problem | 18 | $69 | $264 |
| Ct scan of abdomen and pelvis without contrast | 17 | $76 | $560 |
| Basic metabolic blood panel | 15 | $8 | $49 |
| Office visit, established patient, complex (40-54 min) | 12 | $137 | $496 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Athar is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 15% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Athar experienced with iron sucrose injection (venofer)?
Does Dr. Athar receive payments from pharmaceutical companies?
How do Dr. Athar's costs compare to other internal medicine physicians in Mckinney?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology